Loading Events

« All Events

  • This event has passed.

Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases

December 9, 2019 @ 9:00 am - 4:45 pm

Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases

December 9

Silver Spring, Maryland

Scott Siler will provided commentary on the presentations during “Session 4: Clinical Trial Design and Endpoint Selection: Clinical Pharmacology Approaches to Optimizing the Safety and Efficacy of Therapies for NASH and Cholestatic Liver Diseases” in addition to providing a very brief (5 min) presentation of how QSP modeling can help with optimizing clinical trial design.

 

Venue

Sheraton Silver Spring Hotel
8777 Georgia Avenue
Silver Spring, MD 20910 United States
+ Google Map
Phone:
301-589-0800
Website:
https://www.marriott.com/hotels/travel/wassg-sheraton-silver-spring-hotel/

In Case You Missed A Recent Webinar or Product Video:

What’s new in MonolixSuite 2021

ADMET Predictor® 10.3 (APX.3): Flagship machine learning platform for ADMET modeling